Results 141 to 150 of about 8,505 (243)

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings

International Journal of Methods in Psychiatric Research, Volume 35, Issue 2, June 2026.
ABSTRACT Objectives For English, the validated part of Psychedelic Experience Scale (PES48) is a four‐factor structure called the Mystical Experience Questionnaire (MEQ30). The other validated part of the PES48 consists of four more factors: two more mystical factors (paradoxicality and connectedness, which together with the MEQ30 form the MEQ40), and ...
Kurt Stocker, Matthias Hartmann, Frederick S. Barrett, William A. Richards, Nathan D. Sepeda, Laura Ley, Anna M. Becker, Friederike Holze, Matthias E. Liechti   +8 more
wiley   +1 more source

Neotrance and the Psychedelic Festival

Dancecult, 2009
This article explores the religio-spiritual characteristics of psytrance (psychedelic trance), attending specifically to the characteristics of what I call neotrance apparent within the contemporary trance event, the countercultural inheritance of the “tribal” psytrance festival, and the dramatizing of participants’ “ultimate concerns” within the ...
openaire   +4 more sources

The role of modern neuroscience in the renaissance of psychedelic research

Revista Costarricense de Psicología
The primary objective of this review is to highlight the increasing relevance of experimental neuroscience in advancing the mechanistic understanding and translational potential of classic psychedelics and other psychoactive substances of interest ...
Kathryn Evans, Crystian Massengill, Jonnathan Singh Alvarado   +2 more
doaj   +1 more source

Demoralization and Associated Factors in Palliative Oncology Outpatients: A Cross‐Sectional Study

Psycho-Oncology, Volume 35, Issue 6, June 2026.
ABSTRACT Background Demoralization is common in palliative psycho‐oncology settings. Although its relationship with other psycho‐existential conditions has been scrutinized, its co‐occurrence with adjustment disorder, as measured by the Adjustment Disorder New Module‐20 (ADNM‐20), remains unexamined.
Michael Ljuslin, Vasileios Chytas, Marie‐Estelle Gaignard, Daniel Gorman, Kate Lally, Emanuele Mazzola, Kabir Nigam, Sholevar Roxanne, Zachary Sager, Miryam Yusufov, Sophie Pautex, James Aaron Tulsky, Yvan Beaussant   +12 more
wiley   +1 more source

PSYCHEDELICS: CLINICAL EVIDENCE AND THERAPEUTIC MECHANISMS IN PSYCHIATRY [PDF]

Psychiatria Fennica
Interest and academic research on psychedelics and psychedelic-assisted therapy in the treatment of psychiatric disorders has increased dramatically in the past two decades. In many ways, psychedelics represent a new therapeutic paradigm in the context
JANI KAJANOJA, OSKARI KANTONEN, JUUSO KÄHÖNEN
doaj  

Psychedelics as a potential treatment for tobacco use disorder: a systematic review

Discover Mental Health
Introduction Despite considerable efforts, tobacco use disorder persists as a significant public health issue. The effectiveness of current smoking cessation therapies is limited, leading to a growing interest in alternative treatment approaches such as ...
S. K. Spoelstra, R. A. Schoevers, S. D. Venema, H. Knegtering   +3 more
doaj   +1 more source

Recreational Drug Use Amongst Children and Adolescents Presenting to Australian Emergency Departments With Acute Behavioural Disturbance: A Secondary Analysis of a Randomised Controlled Trial

Emergency Medicine Australasia, Volume 38, Issue 3, June 2026.
ABSTRACT Objectives To describe the historical and current use of recreational drugs by a trial cohort of youth presenting to the emergency department (ED) whilst experiencing acute behavioural disturbance (ABD). Methods This was a secondary analysis of a randomised, controlled trial comparing medication management of ABD in children and adolescents ...
Elyssia M. Bourke, Kate Klein, Chris J. Selman, Katherine J. Lee, Amit Kochar, Deborah Shellshear, Meredith L. Borland, Shane George, Shefali Jani, Doris Tham, Michael Gordon, Chidambaram Prakash, Andrew Davidson, Catherine L. Wilson, Natalie Phillips, Gaby Nieva, Jonathan C. Knott, Franz E. Babl, Simon S. Craig, on behalf of the Paediatric Research in Emergency Departments International Collaborative (PREDICT) network, Hanan ElGharib, Lauren Page, Vivian Truong, Naomi Loftus, Danielle Kallianiotis, Amy Carle, Amanda Williams, Bojana Gladanac, Sharon O'Brien, Patricia Clifford, Melissa O'Brien Smith, Anne‐Maree O'Regan, Lisa Properjohn, Katy Whitten, Catherine Power, Gaby Nieva, Simone Hughes, Lara Caruso, Katie Northcott, Natalie Phillips, Angus Jones, Anne Hinde, Amy Coulson, Nadia Schmidt, Jessica Waghorn, Marietta John‐White, Riku Haataja, Zachary Wilder, Deepali Thosar, Areeba Athar, Stuart Dalziel, Thomas Sullivan, Gerben Keijzers, Stephen Hearps, Marian Chandler, Kathleen Alleaume‐Ross, Jodie Miers, M. D. Kabir, Diana Mercuri   +58 more
wiley   +1 more source

Neuroaesthetics of the psychedelic state

Neuropsychologia
Neuroaesthetics is a subdiscipline within cognitive neuroscience which describes the biological mechanisms of aesthetic experiences. These experiences encompass perceptions and evaluations of natural objects, artwork, and environments that are ubiquitous in daily life.
Jake Hooper, Devon Stoliker, Kyle Wolfe, Kent Hutchison   +3 more
openaire   +2 more sources

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, Volume 121, Issue 6, Page 1616-1621, June 2026.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source

Latin American adults who regularly use macrodoses of psychedelics: a cross-sectional study

Scientific Reports
Psychedelics have a complex history marked by traditional use among indigenous cultures, early scientific interest, and subsequent prohibition. Despite their classification as controlled substances, recent decades have witnessed a resurgence of research ...
Oscar Véliz-García, Marcos Domic-Siede
doaj   +1 more source